92 related articles for article (PubMed ID: 1546533)
1. Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
Lycke J; Andersen O; Svennerholm B; Ben-Menachem E; Horal P; Vahlne A
Acta Neurol Scand; 1992 Jan; 85(1):44-54. PubMed ID: 1546533
[TBL] [Abstract][Full Text] [Related]
2. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
[TBL] [Abstract][Full Text] [Related]
3. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
[TBL] [Abstract][Full Text] [Related]
4. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.
Mosadeghi P; Heydari-Zarnagh H
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):144-150. PubMed ID: 29757587
[TBL] [Abstract][Full Text] [Related]
6. High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers.
Sawada T; Tohmatsu J; Obara T; Koide A; Kamihira S; Ichimaru M; Kashiwagi S; Kajiyama W; Matsumura N; Kinoshita K
Jpn J Cancer Res; 1989 Jun; 80(6):506-8. PubMed ID: 2503470
[TBL] [Abstract][Full Text] [Related]
7. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.
Washitani Y; Kuroda N; Shiraki H; Itoyama Y; Sato H; Ohshima K; Kiyokawa H; Maeda Y
J Clin Microbiol; 1992 Feb; 30(2):287-90. PubMed ID: 1537894
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
Kuroda N; Washitani Y; Shiraki H; Kiyokawa H; Ohno M; Sato H; Maeda Y
Int J Cancer; 1990 May; 45(5):865-8. PubMed ID: 2185995
[TBL] [Abstract][Full Text] [Related]
9. Human T-lymphotropic virus type I infection in the Solomon Islands.
Yanagihara R; Ajdukiewicz AB; Garruto RM; Sharlow ER; Wu XY; Alemaena O; Sale H; Alexander SS; Gajudusek DC
Am J Trop Med Hyg; 1991 Feb; 44(2):122-30. PubMed ID: 2012254
[TBL] [Abstract][Full Text] [Related]
10. Examination of HTLV-I ELISA-positive leukemia/lymphoma patients by western blotting gave mostly negative or indeterminate reaction.
Srivastava BI; Gonzales C; Loftus R; Fitzpatrick JE; Saxinger CW
AIDS Res Hum Retroviruses; 1990 May; 6(5):617-27. PubMed ID: 2113820
[TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunosorbent assay for immune complex of HTLV-I.
Ishibashi K; Hanada S; Uozumi K; Otsuka M; Sakurami T; Hashimoto S
J Immunol Methods; 1989 May; 119(2):217-21. PubMed ID: 2786036
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
[TBL] [Abstract][Full Text] [Related]
13. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human T cell leukemia virus-I (HTLV-I) antibody among populations living in the Amazon region of Brazil (preliminary report).
Nakauchi CM; Linhares AC; Maruyama K; Kanzaki LI; Macedo JE; Azevedo VN; Casseb JS
Mem Inst Oswaldo Cruz; 1990; 85(1):29-33. PubMed ID: 2215230
[TBL] [Abstract][Full Text] [Related]
15. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
Kitze B; Puccioni-Sohler M; Schäffner J; Rieckmann P; Weber T; Felgenhauer K; Bodemer W
Acta Neurol Scand; 1995 Sep; 92(3):213-7. PubMed ID: 7484074
[TBL] [Abstract][Full Text] [Related]
16. Seroreactivity to human T cell leukemia/lymphoma virus type 1 and related retroviruses in multiple sclerosis patients from Denmark and the Faroes.
Rasmussen HB; Kvinesdal BB; Clausen J
Acta Neurol Scand; 1992 Jul; 86(1):91-4. PubMed ID: 1325731
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
Aboulafia DM; Bennett C; Koga H; Keith D; Slamon D
Viral Immunol; 1992; 5(2):105-11. PubMed ID: 1616582
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
[TBL] [Abstract][Full Text] [Related]
19. Evidence of HTLV-I infection in Singapore prostitutes.
Sng EH; Thirumoorthy T; Levin A; Alexander S; Sng I; Blattner W
Int J STD AIDS; 1991; 2(3):172-5. PubMed ID: 1863647
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins.
Rudolph DL; Lal RB
Clin Chem; 1993 Feb; 39(2):288-92. PubMed ID: 7679339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
